June 2, 2019 / 11:40 AM / 3 months ago

BRIEF-Roche's Tecentriq In Combination With Avastin And Chemotherapy Shows Positive Data In Those With Liver Metastases

June 2 (Reuters) - Roche Holding AG:

* ROCHE’S TECENTRIQ IN COMBINATION WITH AVASTIN AND CHEMOTHERAPY FOR THE INITIAL TREATMENT OF PEOPLE WITH A SPECIFIC TYPE OF METASTATIC LUNG CANCER SHOWS POSITIVE DATA IN THOSE WITH LIVER METASTASES

* ROCHE HOLDING - SAFETY FOR TECENTRIQ, AVASTIN, AND CHEMOTHERAPY COMBINATION APPEARED CONSISTENT WITH KNOWN SAFETY PROFILES OF INDIVIDUAL MEDICINES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below